Sequence information
Variant position: 844 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 2839 The length of the canonical sequence.
Location on the sequence:
GSIDLSDTDSLQEWINMTGF
L CALGGVCLQQRSNSGLATYS
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human GSIDLSDTDSLQEWINMTGFL CALGGVCLQQRSNSGLATYS
Mouse GSIDLSDTDSLQEWINMTGFL CALGGVCLQQRSSSGLATYS
Rat GSIDLSDTDSLQEWINMTGFL CALGGVCLQQRSSSGLATYS
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Literature citations
Characterization and significance of nine novel mutations in exon 16 of the neurofibromatosis type 1 (NF1) gene.
Maynard J.; Krawczak M.; Upadhyaya M.;
Hum. Genet. 99:674-676(1997)
Cited for: VARIANTS NF1 ARG-844 AND PRO-898;
Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type.
Wang Q.; Montmain G.; Ruano E.; Upadhyaya M.; Dudley S.; Liskay R.M.; Thibodeau S.N.; Puisieux A.;
Hum. Genet. 112:117-123(2003)
Cited for: VARIANTS NF1 TYR-93; VAL-604; ARG-844 AND PRO-898; VARIANTS ASP-74; GLU-176; ARG-712 AND GLN-1276;
Neurofibromatosis-Noonan syndrome: molecular evidence of the concurrence of both disorders in a patient.
Bertola D.R.; Pereira A.C.; Passetti F.; de Oliveira P.S.L.; Messiaen L.; Gelb B.D.; Kim C.A.; Krieger J.E.;
Am. J. Med. Genet. A 136:242-245(2005)
Cited for: VARIANT NF1 ARG-844;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.